Inhaled treprostinil is the only approved therapy with randomized evidence for pulmonary hypertension associated with interstitial lung disease
Inhaled treprostinil shows promise for specific types of lung disease
This narrative review examines pharmacological management of pulmonary hypertension associated with interstitial lung disease (PH-ILD) and i…
New research clarifies which treatments actually work for patients facing both pulmonary hypertension and scarring of the lungs.
Narrative review finds insufficient evidence for CFTR modulator monotherapy in cystic fibrosis with F508del homozygosity
New review shows single drug therapy does not help people with cystic fibrosis who have two F508del gene variants
This narrative review synthesized evidence from 10 early-phase trials on CFTR modulator monotherapy for cystic fibrosis with F508del homozyg…
A review of early studies found that taking one CFTR modulator drug alone does not improve survival, lung function, or quality of life for p…